Healthcare Stocks

GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

 GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

Highlights  The UK-based GlaxoSmithKline has received initial approval from the UK regulator for its sotrovimab, a monoclonal antibody, which could be effective against Omicron variant. The UK pharmaceutical industry received a significant...

Read More...
AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

Summary The executive vice-president at AstraZeneca biopharmaceuticals R&D Sir Menelas Pangalos has expressed his doubts over early FDA approval for their vaccine AstraZeneca has been facing criticism since it paused its Phase 3 trials in S...

Read More...
Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

The fully integrated specialty pharmaceutical group, Allergy Therapeutics PLC has said that all the resolutions which were proposed at its Annual General Meeting (AGM) on Tuesday were passed, barring one the resolution 10. Resolution 10 talks abou...

Read More...
Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

Summary US FDA has commended the expeditious response of Pfizer and BioNTech in Covid-19 vaccine development Pfizer-BioNTech co-developed coronavirus vaccine exhibits safety and overwhelmingly high efficacy In a further advancement in the ...

Read More...
What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

Summary N4 Pharma Plc has reported an increase of 5.9% in operating loss during H1 FY20. The Company has started the first phase of research to test the stability of different formulations of Nuvec® in collaboration with Nanomerics Limited....

Read More...
Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

The United Kingdom administration is all set to get the very first doses of the clinically-approved coronavirus vaccine developed by Pfizer-BioNTech much ahead than other countries, especially the United States, where the vaccine is still under Foo...

Read More...
Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay

Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay

Summary In a first, the UK has swiftly approved the Pfizer-BioNTech developed coronavirus vaccine The drug regulators across various nations including the US and the EU’s basket of countries are working on expediting the approval process ...

Read More...
MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week

MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week

In a historic development, the Medicines and Healthcare Products Regulatory Authority (MHRA) of the United Kingdom has given approval to the Pfizer-BioNTech vaccine. With this, the UK has become the first western country ahead of the US and Europe to...

Read More...
UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'

UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'

In a major development, the United Kingdom on Wednesday became the first nation to approve the Pfizer-BioNTech vaccination for public use. The COVID-19 mRNA vaccine candidate will be rolled out from next week, informed UK health secretary Matt Hancoc...

Read More...
AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe

AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe

AstraZeneca PLC (LON: AZN) will be selling its rights of Crestor and some related medicines to Germany-based Grünenthal GmbH in more than 30 countries of Europe except the UK and Spain. The deal is worth up to $350 million. AstraZeneca will con...

Read More...
Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday

Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday

Shares of Indivior, the Chesterfield-headquartered pharmaceuticals company, crashed nearly 20 per cent at the close of the trading window on Friday, 28 November after the Slough-based healthcare-to-consumer goods manufacturer Reckitt Benckiser Group ...

Read More...